The role of insulin resistance and insulin-sensitizers in NASH management: tips for the practicing clinician

Prof. Rautou, France, discusses a critical component of the diagnosis and management of NASH: biomarkers. There are 2 aspects: fibrosis and diagnosis. Diagnosis is a field of investigations. Microvesicles could play a role.

Prof Kenneth Cusi, USA, discusses the role of insulin sensitizers in NASH, and particularly how lifestyle interventions including weight loss can, in this context, be beneficial together with a pharmacological approach. This video was filmed in Boston during the Liver meeting 2019.

Share the article
Avatar photo

Prof. Kenneth Cusi

Prof. Kenneth Cusi, a leading expert in Endocrinology, currently serves as the Chief of the Division of Endocrinology at the University of Florida. Renowned for his groundbreaking work on the correlation between NAFLD and T2DM, Prof. Cusi has published over 150 articles in leading medical journals and received numerous accolades for his contributions to medicine.

Articles: 9

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *